Prevalence of metabolic abnormalities in the Tunisian adults: A population based study

Diabetes and Metabolism

Volumn 32, Issue 3, 2006, Pages 215-221

  Bouguerra, R ^a   Ben Salem, L ^a   Alberti, H ^b   Ben Rayana, C ^a   El Atti, J ^a   Blouza, S ^a   Gaigi, S ^a   Achour, A ^a   Ben Slama, C ^a   Zouari, B ^c  

^a Institut National de Nutrition Tunis   (Tunisia)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF TUNIS EL MANAR   (Tunisia)

Author keywords

Cluster of metabolic abnormalities; Epidemiology; Metabolic abnormalities; Prevalence; Tunisia; Urban residency

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT;

ABDOMEN; ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY HEIGHT; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CLUSTER ANALYSIS; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH SURVEY; HUMAN; HYPERTRIGLYCERIDEMIA; MALE; METABOLIC DISORDER; NUTRITIONAL STATUS; OBESITY; POPULATION RESEARCH; PREVALENCE; RURAL POPULATION; TRIACYLGLYCEROL BLOOD LEVEL; TUNISIA; URBAN POPULATION; WAIST CIRCUMFERENCE;

EID: 33745668154     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1262-3636(07)70271-9     Document Type: Article

References (31)

1. Reaven MG. Role of insulin resistance in Human disease. Banting lecture 1988. Diabetes 1988;37:1595-607.
2. Reaven MG. The fourth Musketeer - From Alexandre Dumas to Claude Bernard. Diabetologia 1995;38:3-13.
3. Meigs JB. Invited Commentary: insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors. Am J Epidemiol 2000;152:908-11.
4. Meigs JB. Metabolic syndrome: in search of a clinical role. Diabetes Care 2004;27:2761-3.
5. Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C. Definition of metabolic syndrome. Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition. Circulation 2004;109:433-8.
6. Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome. Diabetes Care 2005;28:1769-78.
7. Bloomgarden ZT.American Association of Clinical Endocrinologists (AACE) Consensus Conference on the Insulin Resistance Syndrome. Diabetes Care 2003;26:933-9.
8. The European Group for the study of Insulin Resistance (EGIR). Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes Metab 2002;28:364-76.
9. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
10. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005;365:1415-28.
11. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among U.S adults. Findings from the third National Health and Nutrition Examination Survey. JAMA 2002;287:356-9.
12. Parikka PI, Eriksson JG, Lindström J, et al. Prevalence of the metabolic syndrome and its components Findings from a finnish general population sample and the diabetes prevention study cohort. Diabetes Care 2004;27:2135-40.
13. Balkau B, Vernay M, Mhamdi L, et al. The Incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome. The French D.E.S.I.R. study. Diabetes Metab 2003;29:526-32.
14. Rguibi M, Belahsen R. Metabolic syndrome among Moroccan Sahraoui adult women. Am J Hum Biol 2004;16:598-601.
15. Al-Lawati JA, Mohammed AJ, Al-Hinal HQ, Jousilahti P. Prevalence of the metabolic syndrome among Omani adults. Diabetes Care 2003;26:1781-5.
16. Simons LA. Interrelations of lipids and lipoproteins with coronary artery disease mortality in 19 countries. Am J Cardiol 1986;57:5G-10G.
17. Chen Z, Peto R, Collins R, MacMahon S, Lu J, Li W. Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations. BMJ 1991;303:276-82.
18. World Health Organisation. Global prevalence and secular trends in obesity. In: Obesity: preventing and managing the global epidemic. Report of a WHO consultation. Geneva: 1997;17-40.
19. Al-Mahroos F, McKeigue PM. High prevalence of diabetes in Bahrainis. Associations with ethnicity and raised plasma cholesterol. Diabetes Care 1998;21:936-42.
20. Meigs JB, Nathan DM, D'Agostino RB, Wilson PWF. Fasting and post challenge glycaemia and cardiovascular disease risk. The Framingham Offspring Study. Diabetes Care 2002;25:1845-50.
21. Abdul-Rahim HF, Husseini A, Bjertness E, Giacaman R, Gordon NH, Jervell J. The metabolic syndrome in the west bank population. An urban-rural comparison. Diabetes Care 2001;24:275-9.
22. Tolonen H, Keil U, Ferrario M, Evans A. Prevalence, awareness and treatment of hypercholesterolaemia in 32 populations: results from the WHO MONICA Project. Inter J Epidemiol 2005;34:181-92.
23. Sempos CT, Cleeman JI, Carroll MD, et al. Prevalence of high blood cholesterol among US adults. An update based on guidelines from the Second Report of the National Cholesterol Education Program Adult Treatment Panel. JAMA 1993;269:3009-14.
24. Jaber LA, Brown MB, Hammad A, Zhu Q, Herman WH. The prevalence of the metabolic syndrome among Arab Americans. Diabetes Care 2004;27:234-8.
25. Han TS, van Leer EM, Seidell JG, Lean MEJ. Waist circumference action levels in the identification of cardiovascular risk factors: prevalence study in a random sample. BMJ 1995;311:1401-5.
26. Papoz L, Ben khalifa F, Eschwege E, Ben Ayed H. Diabetes Mellitus in Tunisia: Description in urban and rural populations. Inter J Epidemiol 1988;17:419-22.
27. World Health Organisation. Factors influencing the development of overweight and obesity. In: Obesity preventing and managing the global epidemic. Report of a WHO consultation. Geneva: 1997;107-58.
28. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025. Prevalence, numerical estimates, and projections. Diabetes Care 1998;21:1414-31.
29. Jabbour S. Health and development in the Arab world: which way forward? BMJ 2003;326:1141-3.
30. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome. Prevalence and associated risk factor findings in the US population from the third national health and nutrition examination survey, 1988-1994. Arch Intern Med 2003;163:427-36.
31. Zimmet P. The burden of type 2 diabetes: are we doing enough? Diabetes Metab 2003;29:6S9-6S18.